Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Azam

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansionIsak W Tengesdal, Dinoop R Menon, Douglas G Osborne, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2018
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammationCarlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansionIsak W Tengesdal, Dinoop R Menon, Douglas G Osborne, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2018
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammationCarlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni, et al.
Pageof 6